After Asian Paint’s Fall, Is There Pain In Store For Paint Companies?
.jpg)
Asian Paints has corrected over 11 percent from the lifetime high it registered in October. But its peers like Berger Paints, Kansai Nerolac and Akzo Nobel have not budged and continue to trade near their respective record highs.
Berger Paints has gained over 10 percent in the last 3 months whereas Kansai Nerolac and Akzo Nobel have gained between 1 to 2 percent. Asian Paints in comparison, has retreated over 3 percent in the same period.
Why the split?
Asian Paints traded at a substantial premium of 55 times forward price-to-earnings (PE) before its correction. It is now trading at 49 times, more in line with its peers like Berger Paints, which trades at 51 times, Kansai Nerolac at 44 times and Akzo Nobel at 42 times.
With respect to the companies' profit return ratios, little has changed with all four companies reporting steady second quarter earnings which were in-line with expectations. Historically, Asian Paints has always traded at a premium to its peers owing to its superior ratios. So given Asian Paints has broken away and declined, will the rest follow?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.
